相关临床试验
1
0 进行中
药物批准
0
批准总数
监管机构
0
监管机构数
成立时间
N/A
已完成
1
100.0%
暂无批准数据
- Despite an ongoing Ebola outbreak in Congo and Uganda designated a public health emergency, experts say the risk of Ebola transmission during the World Cup is extremely low due to its non-respiratory spread. - Measles is the primary concern for public health officials, given its extreme contagiousness, rising U.S. cases (over 2,100 in 2025), and declining vaccination rates. - Host cities are scaling up wastewater surveillance, mobile testing labs, and cross-jurisdictional coordination through new initiatives like Georgetown's Health Security Operations Center. - Respiratory viruses such as Covid-19 and influenza, as well as norovirus and foodborne illnesses, also pose notable risks during the multi-city, three-country tournament.
- Curavit Clinical Research completed recruitment of 298 participants for the APPROVE trial evaluating RiSolve digital therapeutic for overactive bladder in women, finishing two months ahead of the six-month timeline. - The randomized trial compares Amara Therapeutics' prescription digital therapeutic application to standard behavioral education, aiming to generate FDA marketing clearance data. - The virtual clinical site model demonstrated significant efficiency gains, with Curavit's STRATUS platform enabling rapid enrollment despite complex screening requirements including multi-day diaries and medical record collection. - The accelerated recruitment timeline showcases the potential of decentralized clinical trials to expedite delivery of evidence-based digital therapies for women's health conditions.
- MedHub-AI's AutocathFFR® becomes the first fully automated AI-powered software to receive PMDA approval in Japan for calculating Fractional Flow Reserve values directly from X-ray angiograms without invasive procedures. - The approval is supported by a pivotal study of 504 vessels demonstrating 93.7% diagnostic accuracy, 90.2% sensitivity, and 94.9% specificity compared to traditional invasive FFR measurements. - The company has partnered with Terumo Corporation for Japanese market distribution and expects FDA approval in the near future to accelerate global expansion. - AutocathFFR® delivers FFR results in just 37 seconds, eliminating the need for guidewires and vasodilatory drugs while providing operator-independent decision support for cardiologists.
- Georgetown University and MedStar Health researchers developed a blood test that uses circulating cell-free DNA fragments to detect early signs of liver transplant rejection and complications. - The technology analyzes DNA methylation patterns to identify the specific cellular origin of organ damage, enabling more targeted treatment approaches. - This liquid biopsy approach could replace invasive liver biopsies and provide continuous monitoring of transplant recipients with greater accuracy. - The research, funded by a $2.5 million NIH grant, represents a major advancement in post-transplant care and has potential applications in other organ transplants and cancer treatment.
- Pharmacists are taking on expanded roles in shared decision-making for multiple sclerosis treatment, helping patients navigate complex B-cell therapies and improving treatment adherence. - Clinical pharmacists are actively collaborating with physicians to provide comprehensive patient education, monitor safety parameters, and manage adverse effects of MS treatments like ofatumumab and ocrelizumab. - Specialty pharmacists are instrumental in overcoming treatment barriers by managing prior authorizations, coordinating care across multiple conditions, and ensuring proper documentation for insurance coverage.
